Published in Clin Exp Immunol on February 01, 1972
Why is the infectious stage of syphilis prolonged? Br J Vener Dis (1974) 2.36
Mechanisms of protective immunity in experimental cutaneous leishmaniasis of the guinea-pig. I. Lack of effects of immune lymphocytes and of activated macrophages. Clin Exp Immunol (1975) 1.42
The role of the macrophage in cutaneous leishmaniasis. Immunology (1975) 1.36
Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice. Infect Immun (1977) 1.23
Alterations of the immune response associated with chronic experimental leishmaniasis. Infect Immun (1979) 1.20
Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol (1974) 1.17
The quantification of viable Leishmania enriettii from infected guinea-pig tissues. Clin Exp Immunol (1979) 1.13
Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide. Clin Exp Immunol (1976) 1.11
The kinetics and quality of acquired resistance in self-healing and metastatic leishmaniasis. Clin Exp Immunol (1979) 1.07
Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63). Clin Exp Immunol (1991) 1.02
Mechanisms of immunity to leishmaniasis. I. Evidence for a changing basis of protection in self-limiting disease. Clin Exp Immunol (1980) 1.01
Numerical immunotaxonomy of Leishmania. I. Differentiation of four strains of Leishmania by serological tests. Immunology (1976) 0.94
Relationship between non-specific activity of macrophages and immune responses to Listeria monocytogenes. Immunology (1980) 0.91
Cytophilic and opsonic antibodies in visceral leishmaniasis in mice. Infect Immun (1980) 0.90
The effects of protein malnutrition on the course of Leishmania mexicana infection in C57Bl/6 mice: nutrition and susceptibility to leishmaniasis. Clin Exp Immunol (1979) 0.89
Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis. Infect Immun (1987) 0.88
Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes. Clin Exp Immunol (1987) 0.87
The effect of Leishmania tropica on stimulation of lymphocytes with phytohaemagglutinin. Immunology (1976) 0.84
Establishment of cutaneous Leishmania enriettii infection in hamsters. Infect Immun (1976) 0.81
Effect of visceral leishmaniasis on congenitally athymic mice. Infect Immun (1979) 0.80
Role of macrophages in host defense against hepatic amoebiasis in hamsters. Infect Immun (1983) 0.79
Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections. Clin Exp Immunol (1980) 0.78
Influence of rodent malaria on the course of Leishmania enriettii infection of hamsters. Infect Immun (1976) 0.77
In vitro suppression of lymphocyte blastogenic response to mitogen and antigen by Leishmania tropica. Clin Exp Immunol (1978) 0.75
Immunology in cutaneous leishmaniasis. Proc R Soc Med (1973) 0.75
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
Delayed hypersensitivity. III. Specific desensitization of guinea pigs sensitized to protein antigens. J Exp Med (1958) 3.52
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
Granuloma formation in lymph-nodes. J Pathol (1970) 1.54
Anti-lymphocytic antibody and autoimmune disease: a review. Clin Exp Immunol (1969) 1.53
Impairment of immunological reactivity in guinea pigs by prior injection of adjuvant. Nature (1962) 1.47
Factors influencing the immune response. 3. The blocking effect of Corynebacterium parvum upon the induction of acquired immunological unresponsiveness to bovine serum albumin in the adult rabbit. Clin Exp Immunol (1968) 1.46
Studies on the immunology and serology of leishmaniasis. V. The use of particles as vehicles in passive agglutination tests. Trans R Soc Trop Med Hyg (1967) 1.37
Immunological aspects of clinical leishmaniasis. Proc R Soc Med (1970) 1.20
Observations on the susceptibility of white mice to infection with Leishmania mexicana following whole-body x-irradiation. Ann Trop Med Parasitol (1968) 1.10
Cutaneous leishmaniasis of the guineapig. Action of sensitised lymphocytes on infected macrophages. Lancet (1968) 1.04
"Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature (1969) 6.42
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
Immunity in cutaneous leishmaniasis of the guinea-pig. Clin Exp Immunol (1970) 4.50
A micro-method for peripheral leucocyte migration in tuberculin sensitivity. J Clin Pathol (1971) 3.45
Immunosuppression in children with malaria. Lancet (1972) 3.11
Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol (1972) 3.08
Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease. Trans R Soc Trop Med Hyg (1969) 2.78
Allergic complications of meningococcal disease. II. Immunological investigations. Br Med J (1973) 2.61
Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am J Trop Med Hyg (1983) 2.57
Malaria at Christmas: risks of prophylaxis versus risks of malaria. BMJ (1998) 2.48
Fever as the presenting complaint of travellers returning from the tropics. QJM (1995) 2.34
Diffuse cutaneous leishmaniasis in Ethiopia. 3. Immunological studies. IV. Pathogenesis of diffuse cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1970) 2.32
Lesions of schistosomiasis mimicking warts on the vulva. BMJ (1993) 2.25
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse. Clin Exp Immunol (1976) 2.20
Interleukin 1 in Crohn's disease. Clin Exp Immunol (1987) 2.18
Tissue-specific antigens. Adv Immunol (1966) 2.15
'Lymphokines': molecular mediators of cellular immune responses in animals and man. Proc R Soc Med (1970) 2.13
Disappearance of immunoglobulin and complement from the Arthus reaction and its relevance to studies of vasculitis in man. Br J Dermatol (1971) 2.11
The role of the macrophage in delayed hypersensitivity. Br Med Bull (1967) 2.07
The clinical significance of mediators of cellular immunity. Clin Allergy (1971) 2.03
Immunosuppression in Kenyan visceral leishmaniasis. Clin Exp Immunol (1983) 2.00
Adverse reactions in expatriates treated with ivermectin. Lancet (1990) 1.98
Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation. Clin Exp Immunol (1972) 1.94
Cell-mediated immunity during natural measles infection. J Clin Invest (1978) 1.93
Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet (1991) 1.87
Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg (1982) 1.85
Pinocytotic uptake and the digestion of hemoglobin in malaria parasites. J Protozool (1965) 1.76
Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin Infect Dis (1996) 1.75
Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet (1982) 1.68
The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig. J Pathol (1971) 1.66
Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today (1993) 1.64
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy. Q J Med (1990) 1.61
In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen. Immunology (1970) 1.60
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ (1998) 1.60
Immunological properties of the surface of parasitic nematodes. Nature (1979) 1.58
Clinical pathology of the Jarisch-Herxheimer reaction. J Infect Dis (1976) 1.56
Lymphocyte mitogenic factor in man. Nature (1969) 1.51
Role of lymphocyte activation products (LAP) in cell-mediated immunity. I. Preparation and partial purification of guinea-pig LAP. Clin Exp Immunol (1972) 1.51
A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull World Health Organ (1975) 1.48
Louse-borne relapsing fever. Q J Med (1970) 1.46
Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet (1983) 1.45
Cytokines in human intraocular inflammation. Curr Eye Res (1992) 1.44
Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.43
Subacute pulmonary granulomatous schistosomiasis: high resolution CT appearances--another cause of the halo sign. Br J Radiol (2001) 1.43
Standardization of the leucocyte migration test. Int Arch Allergy Appl Immunol (1973) 1.39
Leishmania. Annu Rev Microbiol (1974) 1.38
Studies on the immunology and serology of leishmaniasis. V. The use of particles as vehicles in passive agglutination tests. Trans R Soc Trop Med Hyg (1967) 1.37
Gametocyte and gamete development in Plasmodium falciparum. Proc R Soc Lond B Biol Sci (1978) 1.37
The human materno-foetal relationship in malaria: I. Identification of pigment and parasites in the placenta. Trans R Soc Trop Med Hyg (1980) 1.36
The human materno-foetal relationship in malaria. II. Histological, ultrastructural and immunopathological studies of the placenta. Trans R Soc Trop Med Hyg (1980) 1.35
Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note. Br Med J (1980) 1.34
Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. I. Incidence and class specificity. Clin Exp Immunol (1979) 1.33
The Stein and Desowitz haemagglutination test for the detection of antibodies to Plasmodium berghei and Plasmodium vinckei. Ann Soc Belges Med Trop Parasitol Mycol (1965) 1.32
Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Trans R Soc Trop Med Hyg (1985) 1.31
Tissue damage in cattle infected with Theileria annulata accompanied by metastasis of cytokine-producing, schizont-infected mononuclear phagocytes. J Comp Pathol (1999) 1.29
Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis (1993) 1.29
A comparison of three dosage regimens of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. J Infect Dis (1983) 1.28
Cytokines in proliferative vitreoretinopathy. Eye (Lond) (1991) 1.26
Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Trans R Soc Trop Med Hyg (1985) 1.26
Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet (1986) 1.26
Studies of the mechanism of the Jarisch-Herxheimer reaction in louse-borne relapsing fever: evidence for the presence of circulating Borrelia endotoxin. Clin Sci (1972) 1.25
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment. Trans R Soc Trop Med Hyg (1970) 1.23
Falciparum malaria and pregnancy. Trans R Soc Trop Med Hyg (1979) 1.22
Experimental cutaneous leishmaniasis: VI: anergy and allergy in the cellular immune response during non-healing infection in different strains of mice. J Clin Lab Immunol (1978) 1.20
Immunological aspects of clinical leishmaniasis. Proc R Soc Med (1970) 1.20
Experimental cutaneous leishmaniasis. IV. Selective suppression of cell-mediated immunity during the response of guinea-pigs to infection with Leishmania enriettii. Clin Exp Immunol (1974) 1.17
Studies on the immunology and serology of leishmaniasis. IX. Serological investigation of the parasites of Indian kala-azar and Indian post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg (1973) 1.16
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology (1988) 1.15
The life-cycle of primate malaria parasites. Br Med Bull (1982) 1.15
Cell-mediated immunity to Varicella-Zoster antigen in acute Herpes zoster (shingles). Clin Exp Immunol (1973) 1.14
The sequestration of Plasmodium falciparum infected erythrocytes in the placenta. Trans R Soc Trop Med Hyg (1979) 1.13
Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease. Trans R Soc Trop Med Hyg (1982) 1.13
Leucopenia and fever in the "Jarisch-Herxheimer" reaction of louse-borne relapsing fever. Lancet (1968) 1.13
Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies. Trans R Soc Trop Med Hyg (1985) 1.13
A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol (1989) 1.12
Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. Am J Trop Med Hyg (1986) 1.11
Immunoflorescence studies of Leishmania enriettii infection in the guinea pig. Trans R Soc Trop Med Hyg (1974) 1.11
IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol (1996) 1.11
Peripheral leucocyte migration. Inhibited by diphtheroid organisms isolated from patients with rheumatoid arthritis. Ann Rheum Dis (1970) 1.10
The production of lymphocyte mitogenic factor and migration-inhibition factor by antigen-stimulated lymphocytes of subjects with grass pollen allergy. Clin Exp Immunol (1971) 1.09
The parasite causing cutaneous leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg (1973) 1.08
Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA (1973) 1.07
Laryngeal leishmaniasis. J Laryngol Otol (1994) 1.06
Ticks associated with wild mammals in Ghana. Bull Entomol Res (2005) 1.05
Physiologic changes during the Jarisch-Herxheimer reaction in early syphilis. A comparison with louse-borne relapsing fever. Am J Med (1971) 1.05
Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res (1994) 1.05
Simultaneous measurements of the accumulation of isotope-labelled protein and erythrocytes in skin reactions of allergic inflammation in the guinea-pig. Immunology (1972) 1.05